Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.

Abstract:

:Non-Hodgkin lymphomas (NHLs) are the most common cancer to affect pet dogs. In contrast to the many genes whose mutation contributes to lymphomagenesis in humans, relatively little is known about the acquired genetic alterations that lead to canine B-cell lymphomas (cBCLs). We performed a survey of 84 canine NHL tumors to identify genes affected by somatic point mutations. We found mutations affecting TRAF3, which encodes a negative regulator of nuclear factor (NF)-κB, to be a common feature of cBCLs, with mutations observed in 44% of tumors including a combination of somatic and rare germ-line variants. Overall, 30% of the tumors contained ≥1 somatic TRAF3 mutation. The majority of mutations are predicted to cause loss of TRAF3 protein including those impacting reading frame and splicing. To determine whether TRAF3 loss might be relevant to human NHL, we also analyzed 148 human diffuse large B-cell lymphoma (DLBCL) tumors and identified loss of TRAF3 as a common event, affecting ∼9% of DLBCLs, and reduced expression of TRAF3 among deleted cases. This study implicates mutations affecting NF-κB activity as a novel genetic commonality between human and canine NHLs and supports the potential utility of cBCLs with mutated TRAF3 as a model of the more aggressive activated B-cell subgroup of DLBCL.

journal_name

Blood

journal_title

Blood

authors

Bushell KR,Kim Y,Chan FC,Ben-Neriah S,Jenks A,Alcaide M,Fornika D,Grande BM,Arthur S,Gascoyne RD,Steidl C,Morin RD

doi

10.1182/blood-2014-10-602714

subject

Has Abstract

pub_date

2015-02-05 00:00:00

pages

999-1005

issue

6

eissn

0006-4971

issn

1528-0020

pii

blood-2014-10-602714

journal_volume

125

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study.

    abstract::Daratumumab, a monoclonal CD38 antibody, is approved in the treatment of myeloma, but its efficacy and safety in light-chain (AL) amyloidosis has not been formally studied. This prospective phase 2 trial of daratumumab monotherapy for the treatment of AL amyloidosis was designed to determine the safety, tolerability, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019004436

    authors: Sanchorawala V,Sarosiek S,Schulman A,Mistark M,Migre ME,Cruz R,Sloan JM,Brauneis D,Shelton AC

    更新日期:2020-04-30 00:00:00

  • Downregulation of the anti-HLA alloimmune response by variable region-reactive (anti-idiotypic) antibodies in leukemic patients transfused with platelet concentrates.

    abstract::Approximately 30% to 40% of patients with acute leukemia receiving repeated pooled random-donor platelet transfusions develop anti-HLA alloantibodies. Over time, however, serum anti-HLA concentrations decrease in approximately 50% of these patients, despite continued exposure to platelet and/or red blood cell transfus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Atlas E,Freedman J,Blanchette V,Kazatchkine MD,Semple JW

    更新日期:1993-01-15 00:00:00

  • The enzymes of the glycolytic pathway in erythrocytes infected with Plasmodium falciparum malaria parasites.

    abstract::Enzymes of the glycolytic pathway as well as some ancillary enzymes were studied in normal red cells parasitized with Plasmodium falciparum in culture at varying parasitemias as well as in isolated parasites. The levels of all enzymes except diphosphoglycerate mutase, glucose-6-phosphate dehydrogenase, and adenylate k...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Roth EF Jr,Calvin MC,Max-Audit I,Rosa J,Rosa R

    更新日期:1988-12-01 00:00:00

  • Fibrinogen Bern I: substitution gamma 337 Asn-->Lys is responsible for defective fibrin monomer polymerization.

    abstract::An inherited fibrinogen variant, fibrinogen Bern I, was isolated from plasma of an asymptomatic woman. Routine coagulation studies showed prolonged thrombin and reptilase clotting times. Fibrinogen concentration was diminished when determined by a functional assay, but was normal by the heat precipitation method. The ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Steinmann C,Reber P,Jungo M,Lämmle B,Heinemann G,Wermuth B,Furlan M

    更新日期:1993-10-01 00:00:00

  • Recombinant prolylcarboxypeptidase activates plasma prekallikrein.

    abstract::The serine protease prolylcarboxypeptidase (PRCP), isolated from human umbilical vein endothelial cells (HUVECs), is a plasma prekallikrein (PK) activator. PRCP cDNA was cloned in pMT/BIP/V5-HIS-C, transfected into Schneider insect (S2) cells, and purified from serum-free media. Full-length recombinant PRCP (rPRCP) ac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-07-2510

    authors: Shariat-Madar Z,Mahdi F,Schmaier AH

    更新日期:2004-06-15 00:00:00

  • 2-Chlorodeoxyadenosine: an effective new agent for the treatment of chronic lymphocytic leukemia.

    abstract::2-Chlorodeoxyadenosine, a new lymphocyte-selective, anti-neoplastic drug was administered to 18 patients with advanced chronic lymphocytic leukemia of B-cell origin. All patients were resistant to conventional treatment. A total of 44 courses of 2-chlorodeoxyadenosine were completed with minimal toxicity. An overall r...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Piro LD,Carrera CJ,Beutler E,Carson DA

    更新日期:1988-09-01 00:00:00

  • Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

    abstract::Viral infections have been associated with reduced platelet counts, the biological significance of which has remained elusive. Here, we show that infection with encephalomyocarditis virus (EMCV) rapidly reduces platelet count, and this response is attributed to platelet Toll-like receptor 7 (TLR7). Platelet-TLR7 stimu...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2013-11-536003

    authors: Koupenova M,Vitseva O,MacKay CR,Beaulieu LM,Benjamin EJ,Mick E,Kurt-Jones EA,Ravid K,Freedman JE

    更新日期:2014-07-31 00:00:00

  • A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo.

    abstract::We have developed a new helper-dependent (HD) adenoviral vector FTC that contains 3 cis-acting sequences as stuffer DNA: a human fragment of alphoid repeat DNA, matrix-attachment regions (MARs), and the hepatocyte control region enhancer. To determine the most robust human coagulation factor IX (hFIX) expression casse...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.11.3923

    authors: Ehrhardt A,Kay MA

    更新日期:2002-06-01 00:00:00

  • KRASG12D expression in lung-resident myeloid cells promotes pulmonary LCH-like neoplasm sensitive to statin treatment.

    abstract::Langerhans cell histiocytosis (LCH) is a rare histiocytic neoplasm associated with somatic mutations in the genes involved in the RAF/MEK/extracellular signal-regulated kinase (ERK) signaling pathway. Recently, oncogenic mutations in NRAS/KRAS, upstream regulators of the RAF/MEK/ERK pathway, have been reported in pulm...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-02-770149

    authors: Kamata T,Giblett S,Pritchard C

    更新日期:2017-07-27 00:00:00

  • Substitution of the gamma-chain Asn308 disturbs the D:D interface affecting fibrin polymerization, fibrinopeptide B release, and FXIIIa-catalyzed cross-linking.

    abstract::Crystallographic structures indicate that gamma-chain residue Asn308 participates in D:D interactions and indeed substitutions of gammaAsn308 with lysine or isoleucine have been identified in dysfibrinogens with impaired polymerization. To probe the role of Asn308 in polymerization, we synthesized 3 variant fibrinogen...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4296

    authors: Okumura N,Gorkun OV,Terasawa F,Lord ST

    更新日期:2004-06-01 00:00:00

  • Normal cycling patterns of hematopoietic stem cell subpopulations: an assay using long-term in vivo BrdU infusion.

    abstract::It was found in a long-term bromodeoxyuridine (BrdU) infusion study that two or more different subpopulations of bone marrow stem cells exist in mice. One of these subpopulations appears to be noncycling and forms approximately 10% of eight-day CFU-S. Another one, a subpopulation of slowly cycling bone marrow cells, i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pietrzyk ME,Priestley GV,Wolf NS

    更新日期:1985-12-01 00:00:00

  • Requirement of alpha and beta subunit transmembrane helix separation for integrin outside-in signaling.

    abstract::Adhesion to extracellular ligands through integrins regulates cell shape, migration, growth, and survival. How integrins transmit signals in the outside-to-in direction remains unknown. Whereas in resting integrins the alpha and beta subunit transmembrane domains are associated, ligand binding promotes dissociation an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-080077

    authors: Zhu J,Carman CV,Kim M,Shimaoka M,Springer TA,Luo BH

    更新日期:2007-10-01 00:00:00

  • Targeting mitochondria to overcome conventional and bortezomib/proteasome inhibitor PS-341 resistance in multiple myeloma (MM) cells.

    abstract::Bortezomib (PS-341), a selective inhibitor of proteasomes, induces apoptosis in multiple myeloma (MM) cells; however, prolonged drug exposure may result in cumulative toxicity and the development of chemoresistance. Here we show that combining PK-11195 (PK), an antagonist to mitochondrial peripheral benzodiazepine rec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0547

    authors: Chauhan D,Li G,Podar K,Hideshima T,Mitsiades C,Schlossman R,Munshi N,Richardson P,Cotter FE,Anderson KC

    更新日期:2004-10-15 00:00:00

  • Killer cell activity of human monoblastic leukemia cells as detected with a monocyte-specific target cell.

    abstract::Peripheral blood leukemia cells from patients with acute monoblastic leukemia (AMoL) were tested for killer cell activity against target cells that detected natural killer cell-mediated or monocyte-mediated spontaneous cytotoxicity. The fibrosarcoma cell line Wehi 164, pretreated with actinomycin D to induce susceptib...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ziegler-Heitbrock HW,Munker R,Thiel E,Krebs I,Riethmüller G

    更新日期:1985-01-01 00:00:00

  • Regulation of mouse mast cell protease 6 gene expression by transcription factor encoded by the mi locus.

    abstract::The mi locus of mice encodes a member of the basic-helix-loop-helix-leucine zipper (bHLH-Zip) protein family of transcription factors (hereafter called MITF). Because the expression of the mouse mast cell protease 6 (MMCP-6) gene is remarkably reduced in mast cells of mi/mi mutant mice, we investigated the effect of M...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Morii E,Tsujimura T,Jippo T,Hashimoto K,Takebayashi K,Tsujino K,Nomura S,Yamamoto M,Kitamura Y

    更新日期:1996-10-01 00:00:00

  • Acute graft-versus-host disease: a bench-to-bedside update.

    abstract::Over the past 5 years, many novel approaches to early diagnosis, prevention, and treatment of acute graft-versus-host disease (aGVHD) have been translated from the bench to the bedside. In this review, we highlight recent discoveries in the context of current aGVHD care. The most significant innovations that have alre...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-01-514786

    authors: Holtan SG,Pasquini M,Weisdorf DJ

    更新日期:2014-07-17 00:00:00

  • Frontline rituximab, cyclophosphamide, doxorubicin, and prednisone with bortezomib (VR-CAP) or vincristine (R-CHOP) for non-GCB DLBCL.

    abstract::This phase 2 study evaluated whether substituting bortezomib for vincristine in frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy could improve efficacy in non-germinal center B-cell-like diffuse large B-cell lymphoma (non-GCB DLBCL), centrally confirmed by immunohist...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2015-03-632430

    authors: Offner F,Samoilova O,Osmanov E,Eom HS,Topp MS,Raposo J,Pavlov V,Ricci D,Chaturvedi S,Zhu E,van de Velde H,Enny C,Rizo A,Ferhanoglu B

    更新日期:2015-10-15 00:00:00

  • Clinical and molecular characterization of 6 patients affected by severe deficiency of coagulation factor V: Broadening of the mutational spectrum of factor V gene and in vitro analysis of the newly identified missense mutations.

    abstract::Severe factor V (FV) deficiency is a rare bleeding disorder, whose genetic bases have been characterized only in a limited number of cases. We investigated 6 unrelated patients with extremely reduced plasma FV levels, associated with a bleeding tendency ranging from moderately severe to severe. Clinical manifestations...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-03-0922

    authors: Montefusco MC,Duga S,Asselta R,Malcovati M,Peyvandi F,Santagostino E,Mannucci PM,Tenchini ML

    更新日期:2003-11-01 00:00:00

  • Functional-genetic dissection of HDAC dependencies in mouse lymphoid and myeloid malignancies.

    abstract::Histone deacetylase (HDAC) inhibitors (HDACis) have demonstrated activity in hematological and solid malignancies. Vorinostat, romidepsin, belinostat, and panobinostat are Food and Drug Administration-approved for hematological malignancies and inhibit class II and/or class I HDACs, including HDAC1, 2, 3, and 6. We co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-03-632984

    authors: Matthews GM,Mehdipour P,Cluse LA,Falkenberg KJ,Wang E,Roth M,Santoro F,Vidacs E,Stanley K,House CM,Rusche JR,Vakoc CR,Zuber J,Minucci S,Johnstone RW

    更新日期:2015-11-19 00:00:00

  • L-selectin shedding affects bacterial clearance in the lung: a new regulatory pathway for integrin outside-in signaling.

    abstract::Pneumonia induced by Gram-negative bacteria is a common and serious disease associated with high morbidity and mortality. Elimination of bacterial pathogens relies on the recruitment and functions of neutrophils. The adhesion molecule L-selectin has recently been implicated in integrin activation in neutrophils (insid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000685

    authors: Cappenberg A,Margraf A,Thomas K,Bardel B,McCreedy DA,Van Marck V,Mellmann A,Lowell CA,Zarbock A

    更新日期:2019-10-24 00:00:00

  • The structure of the GPIb-filamin A complex.

    abstract::Filamin A (FLNa), a dimeric actin cross-linking and scaffold protein with numerous intracellular binding partners, anchors the platelet adhesion glycoprotein (GP) Ib-IX-V receptor to actin cytoskeleton. We mapped the GPIbalpha binding site to a single domain of FLNa and resolved the structure of this domain and its in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-3964

    authors: Nakamura F,Pudas R,Heikkinen O,Permi P,Kilpeläinen I,Munday AD,Hartwig JH,Stossel TP,Ylänne J

    更新日期:2006-03-01 00:00:00

  • Evaluation of mycophenolate mofetil for initial treatment of chronic graft-versus-host disease.

    abstract::We conducted a double-blind, randomized multicenter trial to determine whether the addition of mycophenolate mofetil (MMF) improves the efficacy of initial systemic treatment of chronic graft-versus-host disease (GVHD). The primary endpoint was resolution of chronic GVHD and withdrawal of all systemic treatment within...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2009-02-202937

    authors: Martin PJ,Storer BE,Rowley SD,Flowers ME,Lee SJ,Carpenter PA,Wingard JR,Shaughnessy PJ,DeVetten MP,Jagasia M,Fay JW,van Besien K,Gupta V,Kitko C,Johnston LJ,Maziarz RT,Arora M,Jacobson PA,Weisdorf D

    更新日期:2009-05-21 00:00:00

  • The inherited diseases of hemoglobin are an emerging global health burden.

    abstract::It is estimated that in excess of 300,000 children are born each year with a severe inherited disorder of hemoglobin and that approximately 80% of these births occur in low- or middle-income countries. As these countries go through an epidemiologic transition, with a reduction in childhood and infant mortality due to ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-01-251348

    authors: Weatherall DJ

    更新日期:2010-06-03 00:00:00

  • Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.

    abstract::One of the most serious complications of successful treatments for Hodgkin's disease is an increased incidence of acute nonlymphocytic leukemia (ANLL) and other malignancies. A retrospective analysis carried out on 1032 consecutive patients with Hodgkin's disease admitted to our Institute between 1965 and 1978 and tre...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Valagussa P,Santoro A,Fossati Bellani F,Franchi F,Banfi A,Bonadonna G

    更新日期:1982-03-01 00:00:00

  • Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis.

    abstract::The zinc finger transcription factor GATA-2 is highly expressed in immature hematopoietic cells and declines with blood cell maturation. To investigate its role in normal adult hematopoiesis, a bicistronic retroviral vector encoding GATA-2 and the green fluorescent protein (GFP) was used to maintain the high levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Persons DA,Allay JA,Allay ER,Ashmun RA,Orlic D,Jane SM,Cunningham JM,Nienhuis AW

    更新日期:1999-01-15 00:00:00

  • ALDH marks leukemia stem cell.

    abstract::In this issue of Blood,Gerber et al use aldehyde dehydrogenase (ALDH) activity to further subdivide the CD34(+)CD38(-) compartment in the bone marrow of acute myeloid leukemia (AML) patients. They identify a unique population with intermediate ALDH activity (ALDH(int)) that contains leukemia stem cells (LSCs). Moreove...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2012-02-406751

    authors: Fleischman AG

    更新日期:2012-04-12 00:00:00

  • Role and initiation mechanism of the interaction of glycoprotein Ib with surface-immobilized von Willebrand factor in a solid-phase platelet cohesion process.

    abstract::To know the role and initiation mechanism of the interaction of glycoprotein (GP) Ib with surface-immobilized von Willebrand factor (vWF), we examined the effect of shear stress levels on platelet binding to vWF-coated plates using a cone-and-plate type viscometer capable of loading various levels of shear stress. The...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tsuji S,Sugimoto M,Kuwahara M,Nishio K,Takahashi Y,Fujimura Y,Ikeda Y,Yoshioka A

    更新日期:1996-11-15 00:00:00

  • Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells.

    abstract::We have previously shown that coculture of human embryonic stem cells (hESCs) for 14 days with immortalized fetal hepatocytes yields CD34(+) cells that can be expanded in serum-free liquid culture into large numbers of megaloblastic nucleated erythroblasts resembling yolk sac-derived cells. We show here that these pri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-102087

    authors: Qiu C,Olivier EN,Velho M,Bouhassira EE

    更新日期:2008-02-15 00:00:00

  • Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells.

    abstract::Polycythemia vera (PV) treatment with interferon α (IFNα) is frequently limited by dose-related toxicity. PV CD34(+) cells are characterized by overexpression of Bcl-xL, which can be antagonized by ABT-737 leading to apoptosis. We explored the effects of ABT-737 and IFNα on PV hematopoiesis. Both IFNα and ABT-737 alon...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-279125

    authors: Lu M,Wang J,Li Y,Berenzon D,Wang X,Mascarenhas J,Xu M,Hoffman R

    更新日期:2010-11-18 00:00:00

  • Plasma glucosylceramide deficiency as potential risk factor for venous thrombosis and modulator of anticoagulant protein C pathway.

    abstract::To assess the relationship between venous thrombosis and plasma glucosylceramide (GlcCer) or phosphatidylethanolamine (PE), plasma levels of GlcCer and PE were determined for 70 venous thrombosis patients referred for evaluation and 70 healthy blood donors. The mean GlcCer level, but not the PE level, was lower in pat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.7.1907

    authors: Deguchi H,Fernández JA,Pabinger I,Heit JA,Griffin JH

    更新日期:2001-04-01 00:00:00